Cytokinetics reported its third quarter 2026 financial results. The stock is up 2.1% on the day at $63.6. Cytokinetics ...

Wall Street rebounds after U.S. midterms, but Jim Cramer warns fundamentals and upcoming economic data matter more than ...

Rose Yao created Hearth Finance, a personal finance dashboard using Plaid API, featuring expense reconciliation and daily ...

Home Depot's rebound depends on lower interest rates and a housing market recovery, though high mortgage costs continue to ...

Arcutis Biotherapeutics stock is up 6.4% today at $34.05 while the company shares its Q3 2026 results and business update.

Michael Kantro observes that the correlation between cap and equal-weighted S&P 500 has dropped to 37%, raising questions ...

AI-focused political groups spent millions in the 2026 U.S. midterms with mixed results, highlighting ongoing debates over AI ...

New York City water finance authority earns AA+ Fitch rating ahead of $400 million bond sale, maintaining a stable outlook ...

Sequoia Mortgage Trust 2026-MED3 secures expected Fitch ratings for its $554.6 million RMBS deal, backed by loans to medical ...

Diversified Energy posts Q3 adjusted EBITDA of 256 million dollars and anticipates closing its Birch acquisition in Q4.

Edgewise Therapeutics announced its financial results for the third quarter of 2026. The announcement also covered recent ...

DBS reports lower third-quarter profits as weaker trading income in Singapore drags results. Earnings fall short of LSEG ...